<DOC>
	<DOC>NCT01740180</DOC>
	<brief_summary>The primary objective of this study is to collect information about how CLIPPERS patients are currently being treated in France.</brief_summary>
	<brief_title>Cortico-saving Treatments Proposed for CLIPPERS: a First Cohort</brief_title>
	<detailed_description>This is an observational study. Data will be prospectively collected, starting with a detailed baseline description of disease and treatment status, followed by updates everything six months for the next three years.</detailed_description>
	<criteria>Patient correctly informed about the study Symptoms and/or clinical signs indicating that the brain stem is affected MRI shows punctate gadolinium highlights and/or curvilinear bridge and/or middle cerebellar peduncles Clinical and radiological cortico sensitivity If a cerebral biopsy has been performed, presence of a lymphocytic, histiocytic or lymphohysticytic infiltrate symptoms and/or clinical signs indicating impairment other than the central nervous system Cortical impairment present on MRI, microbleeds, stenosis on magnetic resonance angiography, or pacchymeningitis Presence of other diseases that could explain such clinical and radiological signs (see inclusion criteria) If a cerebral biopsy has been performed, presence of signs of malignancy (eg, clonal proliferation, cellular atypia), vasculitis, granuloma, or demyelination</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>